Clinical Trials Browser

Phase 2 × Immunoblastic Lymphadenopathy × 90 days × Clear all

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, T-Cell, Peripheral, Enteropathy-Associated T-Cell Lymphoma